DTC Principles Still On PhRMA’s Agenda; J&J Tries Leading By Example
Executive Summary
Pharmaceutical companies should acknowledge that direct-to-consumer advertising may "inadvertently" minimize risk information, incoming Pharmaceutical Research & Manufacturers of America Chairman William Weldon (J&J) told the association's annual meeting in Washington, D.C. March 18
You may also be interested in...
AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots
AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising
AstraZeneca Questions Value Of DTC Ads, But Is Still Launching New TV Spots
AstraZeneca will soon have both experimental and marketplace data to help refine its new policies on direct-to-consumer advertising
FDA’s Crawford Praises DTC Advertising; PhRMA’s Tauzin Pushes For Change
FDA Acting Commissioner Lester Crawford is highlighting the benefits of direct-to-consumer advertising rather than the need for agency regulation of the practice